Modalis Therapeutics Corporation (JP:4883) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Modalis Therapeutics Corporation has finalized the terms for its 13th stock option program, setting the exercise price for share acquisition rights at 7,400 yen per unit, with a total of 2,935 units to be issued. This will result in 293,500 shares of common stock being made available to directors, employees, and subsidiary employees under the new program.
For further insights into JP:4883 stock, check out TipRanks’ Stock Analysis page.